iJOY Lio SS40000: Three-Tank Design E-Cigarette Review and Analysis

Jan.14.2025
iJOY Lio SS40000: Three-Tank Design E-Cigarette Review and Analysis
iJOY launches innovative three-tank e-cigarette, iJOY Lio SS40000, with adjustable ice and sweetness levels in the US market.

Special announcement:

This article is for internal industry communication only and does not make any recommendations for brands or products.

The images presented in this article are only used to depict facts and are not intended as advertisements for any products.

This article prohibits minors from accessing it.


 

iJOY recently launched a new e-cigarette model called the iJOY Lio SS40000, featuring a triple-pod design that allows for adjustable cooling and sweetness levels. The product has already hit the market in the United States.

 

iJOY Lio SS40000: Three-Tank Design E-Cigarette Review and Analysis
iJOY Lio SS40000 | Image source: worldvapeusa

 

Specifically, the product specifications of iJOY Lio SS40000 are as shown in the table below.

iJOY Lio SS40000: Three-Tank Design E-Cigarette Review and Analysis
iJOY Lio SS40000 Product Information | Design: Two to Supreme

 

The main feature of the iJOY Lio SS40000 e-cigarette is its three-pod system design. According to the manufacturer's website, the product includes a total of four ice levels and three sweetness options, allowing users to adjust both independently using two dedicated buttons.

 

In addition, the iJOY Lio SS40000 also features a 3D curved side screen, which can display battery level, e-liquid remaining amount, and monitor information such as ice level and sweetness level.

 

In December, Shenzhen Donghaoxing Technology Co., Ltd.'s e-cigarette brand Artery Vapor also launched a three-pod design e-cigarette, the Artery CL6 Sweet & Ice Control 50K, in the US market. This product also allows for adjusting the level of sweetness and ice. However, compared to the iJOY Lio SS40000, the Artery CL6 Sweet & Ice Control 50K has advantages in terms of the number of puffs and e-liquid capacity. (For more details, please refer to the article "Product | Three-pod design disposable e-cigarette launches in the US, offering adjustable ice and sweetness levels").

 

In the first half of 2024, iJoy has launched the e-cigarette iJoy Bar SD40000 in the United States, which has a capacity of 40,000 puffs. This product is among the first batch of e-cigarettes in the U.S. market to have a puff capacity of 40,000. Up to now, the performance of iJoy's e-cigarette products in terms of puff capacity has not seen any new breakthroughs. (For more details, please refer to "Product | iJoy launches 40,000 puff disposable e-cigarette in the U.S. with support for AI voice control")

 

The iJOY Lio SS40000 has landed on e-cigarette distributor websites such as vapesourcing, midwestgoods, and worldvapeusa, but is currently not available on the official iJOY website.

 


2Firsts will continue to monitor the performance and market trends of global e-cigarette products, providing the public with accurate and authoritative industry information.

 

2FIRSTS is a product column dedicated to providing readers with the latest information on new products in the tobacco industry. In order to collect and share first-hand information from the industry more broadly, 2FIRSTS welcomes readers to submit articles and share the latest products in the e-cigarette field with us.

 

If you have any unique insights or information, please feel free to contact us at info@2firsts.com at any time.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

PMI Q2 Revenue Rises 10.4% as IQOS and VEEV Expand, U.S. ZYN Growth Slows
PMI Q2 Revenue Rises 10.4% as IQOS and VEEV Expand, U.S. ZYN Growth Slows
Philip Morris International’s second-quarter net revenues rose 10.4% to a record $11.19 billion, as heated tobacco and e-vapor expanded across international markets. IQOS remained the main smoke-free growth engine, while VEEV shipments jumped 55.1%. In the United States, however, ZYN shipments increased just 1.8% and consumer offtake was broadly flat to slightly higher. Cigarette volumes also rose, showing that PMI’s transformation is advancing, but growth is becoming increasingly uneven across categories and markets.
PMI
Jul.22
Hawaii Restricts Vape Sales to FDA-Authorized Products, Disposable E-Cigarettes to Be Banned
Hawaii Restricts Vape Sales to FDA-Authorized Products, Disposable E-Cigarettes to Be Banned
Hawaii has enacted two new e-cigarette laws that significantly tighten market access requirements, requiring products to meet FDA authorization standards and banning disposable e-cigarette sales starting in 2027.
Jul.08
Italy Fines PMI €7 Million Over Misleading ‘Smoke-Free Future’ Marketing Claims
Italy Fines PMI €7 Million Over Misleading ‘Smoke-Free Future’ Marketing Claims
Italy’s Competition and Market Authority (AGCM) has fined Philip Morris Italia €7 million, finding that the company’s use of “smoke-free future” and related claims in promoting products such as IQOS, VEEV and ZYN could mislead consumers.
Jun.16
PMI Q2 Call: ZYN Growth, IQOS Pricing and a Diverging Global Tobacco Market
PMI Q2 Call: ZYN Growth, IQOS Pricing and a Diverging Global Tobacco Market
Philip Morris International’s second-quarter earnings call offered new detail on its smoke-free strategy. Management said it would increase U.S. investment behind nicotine pouch brand ZYN, keep IQOS focused on volume before stronger pricing, and use SENTIA, DELIA, LEVIA, VEEV and ZYN to manage tax and regulatory pressure across Japan and Europe. Analysts from Goldman Sachs, Morgan Stanley, UBS and other firms also pressed PMI on profitability, market share, cigarette resilience and the durability of its global transformation over coming quarters.
Jul.24
Philippine Customs Seizes $2.22 Million in Misdeclared Vape Products From China
Philippine Customs Seizes $2.22 Million in Misdeclared Vape Products From China
The Philippine Bureau of Customs said it intercepted nine containers of misdeclared vape and vape-related products from China at the Manila International Container Port, with an estimated value of about ₱137 millionor, about $2.22 million.
Jul.10
Research | Swedish Study Finds Oral Lesions in 79% of Examined Nicotine Pouch Users, With Distinct Tissue Responses
Research | Swedish Study Finds Oral Lesions in 79% of Examined Nicotine Pouch Users, With Distinct Tissue Responses
A new Swedish study found oral mucosal lesions in 79% of examined nicotine pouch users and 89% of tobacco-derived snus users, with different tissue-response patterns between the two categories. For manufacturers and regulators, the findings shift attention toward product formulation, flavouring, pouch materials and local oral exposure, not only whether a product contains tobacco. The study found no higher prevalence of caries or periodontal disease, but it could not establish causality, long-term outcomes or differences between individual products or designs.
Special Report
Jul.27